Elizabeth Livanos

2.5k citations
18 papers · 2.1k indexed · 1 hit paper · h-index 13
Topics
Cancer-related Molecular Pathways (5 papers)Cancer Genomics and Diagnostics (4 papers)Virus-based gene therapy research (3 papers)

In The Last Decade

Elizabeth Livanos

17 papers receiving 2.0k citations

Hit Papers

Altered cell cycle arrest and gene amplification potentia...199220262003201419922505007501000

Peers

Elizabeth Livanos
Comparison fields: 5 of 91
  • Molecular Biology 1.3k
  • Oncology 1.2k
  • Cancer Research 436
  • Genetics 305
  • Epidemiology 277
Replace Jan Kovařík with:
Jan Kovařík Czechia
Berthold Henglein France
Louise Brooks United Kingdom
Tobias Grob Germany
Carlos Caulı́n United States
Kenneth Fernandes United Kingdom
Christian‐Jacques Larsen France
Subrahmanyam Kunala United States
Stuart A.C. McDonald United Kingdom
J M Varley United Kingdom
Elizabeth Livanos relative to Jan Kovařík Czechia Jan Kovařík's profile →
Citations per field
00.5×1.5×1.8×
Jan Kovařík · 1×
Citations per year

Countries citing papers authored by Elizabeth Livanos

Since Specialization
Citations

This map shows the geographic impact of Elizabeth Livanos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Livanos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Livanos more than expected).

Fields of papers citing papers by Elizabeth Livanos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Livanos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Livanos. The network helps show where Elizabeth Livanos may publish in the future.

Co-authorship network of co-authors of Elizabeth Livanos

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth Livanos. A scholar is included among the top collaborators of Elizabeth Livanos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth Livanos. Elizabeth Livanos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
#WorkIndexed citations
1 0
2 78
3 75
4 4
5 16
6 36
7 72
8 13
9 54
10 8
11 298
12 11
13 7
14
Multiple mechanisms of N-(phosphonoacetyl)-L-aspartate drug resistance in SV40-infected precrisis human fibroblasts.
38
15
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53breakdown →
1174
16 85
17 27
18 101

About Elizabeth Livanos

Elizabeth Livanos is a scholar working on Cancer Research, Oncology and Endocrinology, having authored 18 papers that have together received 2.1k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (5 papers), Cancer Genomics and Diagnostics (4 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Oncology (1.2k citations), Biotechnology (261 citations) and Cancer Research (436 citations). Elizabeth Livanos has collaborated with scholars based in United States, Switzerland and Italy. Frequent co-authors include Thea D. Tlsty, Laura R. Livingstone, Tyler Jacks, Alicia White, Jean‐Michel H. Vos, Subrata Banerjee, D Araujo, Bernard E. Weissman, Eric J. Stanbridge and Clare L. Fasching. Their work appears in journals such as Science, Cell and Proceedings of the National Academy of Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026